Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr 15;22(4):437-439.
doi: 10.1093/neuonc/noaa009.

Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features

Patrick J Cimino  1
Affiliations
Editorial

Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features

Patrick J Cimino. Neuro Oncol. .
No abstract available

Keywords: astrocytoma; biomarkers; glioblastoma; grading.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Algorithm to incorporate cIMPACT-NOW Update 3 recommendations for molecular grading of IDH-wildtype diffuse astrocytic gliomas. *Denotes recommended diagnostic entity of molecular glioblastoma put forth by the cIMPACT-NOW Update 3, which Tesileanu et al show has the same survival as traditional histopathologically determined **glioblastoma, IDH-wildtype. (MVP: microvascular proliferation; Amp: amplification; Chr: chromosome.)
See this image and copyright information in PMC

Comment on

References

    1. Louis DN OH, Wiestler OD, Cavenee WK.. WHO Classification of Tumours of the Central Nervous System. 4th ed.Lyon, France: International Agency for Research on Cancer; 2016.
    1. Louis DN, Aldape K, Brat DJ, et al. . Announcing cIMPACT-NOW: the consortium to inform molecular and practical approaches to CNS tumor taxonomy. Acta Neuropathol. 2017;133(1):1–3. - PubMed
    1. Stichel D, Ebrahimi A, Reuss D, et al. . Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol. 2018;136(5):793–803. - PubMed
    1. Aibaidula A, Chan AK, Shi Z, et al. . Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol. 2017;19(10):1327–1337. - PMC - PubMed
    1. Bale TA, Jordan JT, Rapalino O, et al. . Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma. Neuro Oncol. 2019;21(5):596–605. - PMC - PubMed

Substances